Related Experiment Videos

Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure

S A Rivkees1, M Danon, J Herrin

  • 1Pediatric Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston.

Insights

Recombinant growth hormone improved linear growth in most children with prednisone-induced growth failure. However, effectiveness depended on the prednisone dose, with higher doses inhibiting growth hormone benefits.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Pharmacology

Background:

  • Growth failure is a concern in children treated with prednisone.
  • Prednisone can negatively impact linear growth.
  • Recombinant growth hormone (rGH) is a potential therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy of recombinant growth hormone in children with prednisone-induced growth failure.
  • To determine the relationship between prednisone dosage and response to rGH therapy.

Main Methods:

  • Seven children experiencing growth failure due to prednisone treatment were enrolled.
  • Treatment involved administration of recombinant growth hormone.
  • Linear growth rates were monitored before and during rGH therapy.

Main Results:

  • Six out of seven children showed an increase in linear growth with rGH treatment.
  • The response to rGH was dose-dependent.
  • rGH was ineffective in increasing linear growth when prednisone dosage exceeded 0.35 mg/kg/day.

Conclusions:

  • Recombinant growth hormone can be effective in improving linear growth in children with prednisone-induced growth failure.
  • Prednisone dosage is a critical factor influencing rGH efficacy.
  • Lower prednisone doses allow for a better response to rGH therapy.

Related Concept Videos